Paris, France

Aloïse Mabondzo

This inventor holds 5 USPTO granted patents and 3 published patent applications and 3 EPO patents. Top assignees: Commissariat a L'energie Atomique Et Aux Energies Alternatives, Perha Pharmaceuticals, Scientiam Pharma. Active years: 2018-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Aloïse Mabondzo. Retrieved from https://idiyas.com/inventor/aloise-mabondzo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.8

ph-index = 1


Company Filing History:


Years Active: 2018-2026

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Mind of Aloïse Mabondzo

Introduction

Aloïse Mabondzo is an inventive force based in Paris, France. He has made significant contributions to the field of medicine through his innovative research and development of purine derivatives. His patent work focuses on addressing serious health concerns, particularly neurodegenerative and neuro-inflammatory disorders.

Latest Patents

Mabondzo holds a patent for “Purine derivatives for use as medicament and for use in treating neurodegenerative or neuro-inflammatory disorders.” This patent outlines a compound characterized by formula (I) and its addition salts with pharmaceutically acceptable acids. The methods described involve administering an effective amount of the compound or its pharmaceutically acceptable salt to individuals in need of such treatment.

Career Highlights

Throughout his career, Aloïse Mabondzo has worked with esteemed organizations, including the Commissariat à l'Énergie Atomique et aux Énergies Alternatives and Perha Pharmaceuticals. His experience in these institutions has undoubtedly refined his expertise and shaped his innovative approaches to healthcare solutions.

Collaborations

In his professional journey, Aloïse has had the opportunity to collaborate with talented individuals such as Charlotte Leuxe and Anne-Cécile Guyot. These collaborations have allowed him to exchange ideas and advance his research, contributing to his successful patent outcomes.

Conclusion

Aloïse Mabondzo stands out as an innovator dedicated to enhancing medical treatment options through his patented work. His focus on purine derivatives not only exemplifies his commitment to scientific advancement but also highlights the importance of collaboration in the field of innovation. As he continues his work, Mabondzo's research may pave the way for groundbreaking therapies in treating neurodegenerative and neuro-inflammatory disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…